HK1110224A1 - Therapeutic agent for cancer - Google Patents
Therapeutic agent for cancerInfo
- Publication number
- HK1110224A1 HK1110224A1 HK08104563.1A HK08104563A HK1110224A1 HK 1110224 A1 HK1110224 A1 HK 1110224A1 HK 08104563 A HK08104563 A HK 08104563A HK 1110224 A1 HK1110224 A1 HK 1110224A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cancer
- therapeutic agent
- therapeutic
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005181314 | 2005-06-21 | ||
JP2006027581 | 2006-02-03 | ||
PCT/JP2006/312321 WO2006137398A1 (ja) | 2005-06-21 | 2006-06-20 | 癌治療薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1110224A1 true HK1110224A1 (en) | 2008-07-11 |
Family
ID=37570427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08104563.1A HK1110224A1 (en) | 2005-06-21 | 2008-04-24 | Therapeutic agent for cancer |
Country Status (9)
Country | Link |
---|---|
US (1) | US7700546B2 (ko) |
EP (1) | EP1894575B1 (ko) |
JP (1) | JP5052338B2 (ko) |
KR (1) | KR101052090B1 (ko) |
CN (1) | CN101208106B (ko) |
AU (1) | AU2006260240B2 (ko) |
CA (1) | CA2610281C (ko) |
HK (1) | HK1110224A1 (ko) |
WO (1) | WO2006137398A1 (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5110980B2 (ja) * | 2007-06-26 | 2012-12-26 | 一般財団法人阪大微生物病研究会 | 肺がん治療薬 |
FR2988393B1 (fr) | 2012-03-20 | 2014-05-09 | Commissariat Energie Atomique | Inhibiteur de l'hb-egf derive du domaine r de la toxine diphterique pour le traitement des maladies associees a l'activation de la voie hb-egf/egfr |
JP5987175B2 (ja) * | 2012-07-02 | 2016-09-07 | 学校法人福岡大学 | 乳癌,胃癌及び卵巣癌等に対する制癌剤 |
US11965009B2 (en) | 2016-03-10 | 2024-04-23 | The Johns Hopkins University | Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses |
CN109790545A (zh) * | 2016-03-10 | 2019-05-21 | 约翰·霍普金斯大学 | 产生不含聚集物的单体白喉毒素融合蛋白的方法和治疗用途 |
US20200331973A1 (en) * | 2017-09-01 | 2020-10-22 | Lorven Biologics Private Limited | Nucleic acid encoding crm197 and process for improved expression thereof |
WO2020017962A1 (en) | 2018-07-16 | 2020-01-23 | Dcprime B.V. | A combination product for use in tumor vaccination. |
JP2022530044A (ja) | 2019-04-25 | 2022-06-27 | ディーシープライム・ベスローテン・フェンノートシャップ | 腫瘍ワクチン接種方法 |
CA3172449A1 (en) | 2020-03-27 | 2021-09-30 | Erik Hans MANTING | Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4203742B2 (ja) | 2002-10-15 | 2009-01-07 | 財団法人阪大微生物病研究会 | 制癌剤 |
-
2006
- 2006-06-20 JP JP2007522294A patent/JP5052338B2/ja not_active Expired - Fee Related
- 2006-06-20 CN CN2006800220039A patent/CN101208106B/zh not_active Expired - Fee Related
- 2006-06-20 US US11/917,706 patent/US7700546B2/en not_active Expired - Fee Related
- 2006-06-20 CA CA2610281A patent/CA2610281C/en not_active Expired - Fee Related
- 2006-06-20 KR KR1020087000638A patent/KR101052090B1/ko active IP Right Grant
- 2006-06-20 EP EP06766982A patent/EP1894575B1/en not_active Not-in-force
- 2006-06-20 WO PCT/JP2006/312321 patent/WO2006137398A1/ja active Application Filing
- 2006-06-20 AU AU2006260240A patent/AU2006260240B2/en not_active Ceased
-
2008
- 2008-04-24 HK HK08104563.1A patent/HK1110224A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN101208106B (zh) | 2011-07-27 |
EP1894575A4 (en) | 2010-02-24 |
AU2006260240A1 (en) | 2006-12-28 |
EP1894575A1 (en) | 2008-03-05 |
WO2006137398A1 (ja) | 2006-12-28 |
US7700546B2 (en) | 2010-04-20 |
JPWO2006137398A1 (ja) | 2009-01-22 |
CN101208106A (zh) | 2008-06-25 |
AU2006260240B2 (en) | 2012-03-15 |
US20090105135A1 (en) | 2009-04-23 |
CA2610281A1 (en) | 2006-12-28 |
JP5052338B2 (ja) | 2012-10-17 |
CA2610281C (en) | 2014-07-29 |
KR20080017093A (ko) | 2008-02-25 |
KR101052090B1 (ko) | 2011-07-27 |
EP1894575B1 (en) | 2013-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1967209A4 (en) | THERAPEUTIC AGENT AGAINST PROSTATE CANCER | |
EP1876186A4 (en) | PROPHYLACTIC / THERAPEUTIC AGENT FOR CANCER | |
IL190882A0 (en) | Compositions for cancer therapy | |
IL185908A0 (en) | Therapeutic agent for dyskinesia | |
SI3424932T1 (sl) | Boronoftalidi za terapevtsko uporabo | |
GB0521139D0 (en) | Therapeutic agent | |
EP2127671A4 (en) | THERAPEUTIC AGENT AGAINST CANCER | |
GB0516091D0 (en) | Therapeutic agent | |
GB0506147D0 (en) | Therapeutic agents | |
IL197389A0 (en) | Prophylactic or therapeutic agent for cancer | |
EP1797903A4 (en) | DIAGNOSTIC AGENT FOR TUMOR | |
GB0505437D0 (en) | Therapeutic agents | |
GB0505725D0 (en) | Therapeutic agents | |
PT1830847E (pt) | Tratamento para o cancro | |
HK1110224A1 (en) | Therapeutic agent for cancer | |
EP2018873A4 (en) | PROPHYLACTIC / THERAPEUTIC AGENT FOR CANCER | |
EP1923072A4 (en) | MEDICINE FOR PROPHYLAXIS / TREATMENT OF CANCER | |
EP1974732A4 (en) | THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASE | |
IL187792A0 (en) | 4-anilino-3-quinolinecarbonitriles for the treatment of cancer | |
ZA200805522B (en) | Dioxoiane dérivates for the treatment of cancer | |
EP1908467A4 (en) | HERPESVIRUS DERIVED THERAPEUTIC AGENTS AGAINST PAIN | |
GB0508153D0 (en) | Therapeutic agent | |
EP1900363A4 (en) | THERAPEUTIC AGENT AGAINST PAIN | |
GB0507685D0 (en) | Cancer treatment | |
EP1876447A4 (en) | MEANS OF TUMOR DIAGNOSIS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20170620 |